Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
OXYTETRACYCLINE (AS OXYTETRACYCLINE DIHYDRATE PH. EUR.)
Norbrook Laboratories Limited
QJ01AA06
OXYTETRACYCLINE (AS OXYTETRACYCLINE DIHYDRATE PH. EUR.)
Mg/Ml
Solution for Injection
POM
Bovine, Ovine, Porcine
Oxytetracycline
Antibacterial
Authorised
1988-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Alamycin LA 200mg/ml Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance Oxytetracycline (as Oxytetracycline Dihydrate) 200 mg Excipient Sodium Formaldehyde Sulphoxylate 4 mg For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A clear amber solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, sheep, pigs and piglets. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Oxytetracycline is active against a wide range of Gram-positive and Gram-negative pathogenic bacteria, certain rickettsia and the larger viruses. Alamycin LA is indicated in the treatment of a wide range of common systemic, respiratory and local infections caused by or associated with organisms sensitive to oxytetracycline in cattle, sheep and pigs. 4.3 CONTRAINDICATIONS Do not use in animals suffering from hepatic or renal damage. Do not use in animals with known hypersensitivity to Oxytetracycline. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 21/12/2015_ _CRN 7022548_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Do not dilute Alamycin LA. If concurrent treatment is administered, use a separate injection site. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS None known. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Although well tolerated, occasionally a slight local reaction of a transient nature has been observed. 4.7 USE DURING PREGNANCY, LACTATION OR LAY The use of tetracycline during the period of tooth and bo Read the complete document